Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment

Journal of Experimental Medicine

Volumn 202, Issue 12, 2005, Pages 1679-1689

  Chen, Shihao ^a   Kawashima, Hiroto ^a   Lowe, John B ^b   Lanier, Lewis L ^c   Fukuda, Minoru ^a  

^a BURNHAM INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

L SELECTIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELLULAR IMMUNITY; CONTROLLED STUDY; ENDOTHELIUM CELL; LYMPH NODE; MELANOMA B16; METASTASIS; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; FREUND'S ADJUVANT; HOMEODOMAIN PROTEINS; INTERFERON TYPE II; KILLER CELLS, NATURAL; L-SELECTIN; LYMPHATIC METASTASIS; MELANOMA, EXPERIMENTAL; MICE;

EID: 29144530303     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20051473     Document Type: Article

References (54)

1. Colucci, F., M.A. Caligiuri, and J.P. Di Santo. 2003. What does it take to make a natural killer? Nat. Rev. Immunol. 3:413-425.
2. Morris, M.A., and K. Ley. 2004. Trafficking of natural killer cells. Curr. Mol. Med. 4:431-438.
3. Bianchi, G., M. Sironi, E. Ghibaudi, C. Selvaggini, M. Elices, P. Allavena, and A. Mantovani. 1993. Migration of natural killer cells across endothelial cell monolayers. J. Immunol. 151:5135-5144.
4. Allavena, P., G. Bianchi, D. Zhou, J. van Damme, P. Jilek, S. Sozzani, and A. Mantovani. 1994. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immunol. 24:3233-3236.
5. Fogler, W.E., K. Volker, K.L. McCormick, M. Watanabe, J.R. Ortaldo, and R.H. Wiltrout. 1996. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J. Immunol. 156:4707-4714.
6. Schmits, R., T.M. Kundig, D.M. Baker, G. Shumaker, J.J. Simard, G. Duncan, A. Wakeham, A. Shahinian, A. van der Heiden, M.F. Bachmann, et al. 1996. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J. Exp. Med. 183:1415-1426.
7. Barber, D.F., M. Faure, and E.O. Long. 2004. LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173:3653-3659.
8. von Andrian, U.H., and T.R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867-878.
9. Rosen, S.D. 2004. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 22:129-156.
10. Ley, K., and G.S. Kansas. 2004. Selectins in T-cell recruitment to nonlymphoid tissues and sites of inflammation. Nat. Rev. Immunol. 4:325-335.
11. Frey, M., N.B. Packianathan, T.A. Fehniger, M.E. Ross, W.C. Wang, C.C. Stewart, M.A. Caligiuri, and S.S. Evans. 1998. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J. Immunol. 161:400-408.
12. Freud, A.G., B. Becknell, S. Roychowdhury, H.C. Mao, A.K. Ferketich, G.J. Nuovo, T.L. Hughes, T.B. Marburger, J. Sung, R.A. Baiocchi, et al. 2005. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity. 22:295-304.
13. Yago, T., M. Tsukuda, H. Fukushima, H. Yamaoka, K. Kurata-Miura, T. Nishi, and M. Minami. 1998. IL-12 promotes the adhesion of NK cells to endothelial selectins under flow conditions. J. Immunol. 161:1140-1145.
14. Andre, P., O. Spertini, S. Guia, P. Rihet, F. Dignat-George, H. Brailly, J. Sampol, P.J. Anderson, and E. Vivier. 2000. Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Proc. Natl. Acad. Sci. USA. 97:3400-3405.
15. Cerwenka, A., and L.L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:41-49.
16. Diefenbach, A., and D.H. Raulet. 2002. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol. Rev. 188:9-21.
17. Smyth, M.J., Y. Hayakawa, K. Takeda, and H. Yagita. 2002. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer. 2:850-861.
18. Lanier, L.L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
19. Arase, H., E.S. Mocarski, A.E. Campbell, A.B. Hill, and L.L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:1323-1326.
20. Smith, H.R., J.W. Heusel, I.K. Mehta, S. Kim, B.G. Dorner, O.V. Naidenko, K. Iizuka, H. Furukawa, D.L. Beckman, J.T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA. 99:8826-8831.
21. Ferlazzo, G., D. Thomas, S.L. Lin, K. Goodman, B. Morandi, W.A. Muller, A. Moretta, and C. Munz. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172:1455-1462.
22. Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowig, G. Bougras, W.A. Muller, L. Moretta, and C. Munz. 2004. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA. 101:16606-16611.
23. Fehniger, T.A., M.A. Cooper, G.J. Nuovo, M. Cella, F. Facchetti, M. Colonna, and M.A. Caligiuri. 2003. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 101:3052-3057.
24. Cooper, M.A., T.A. Fehniger, and M.A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640.
25. Martin-Fontecha, A., L.L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-γ for T(H)1 priming. Nat. Immunol. 5:1260-1265.
26. Jacob, G.S., C. Kirmaier, S.Z. Abbas, S.C. Howard, C.N. Steininger, J.K. Welply, and P. Scudder. 1995. Binding of sialyl Lewis x to E-selectin as measured by fluorescence polarization. Biochemistry. 34:1210-1217.
27. Ellies, L.G., S. Tsuboi, B. Petryniak, J.B. Lowe, M. Fukuda, and J.D. Marth. 1998. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity. 9:881-890.
28. Yeh, J.C., N. Hiraoka, B. Petryniak, J. Nakayama, L.G. Ellies, D. Rabuka, O. Hindsgaul, J.D. Marth, J.B. Lowe, and M. Fukuda. 2001. Novel sulfated lymphocyte homing receptors and their control by a Core1 extension β 1,3-N-acetylglucosaminyltransferase. Cell. 105:957-969.
29. Homeister, J.W., A.D. Thall, B. Petryniak, P. Maly, C.E. Rogers, P.L. Smith, R.J. Kelly, K.M. Gersten, S.W. Askari, G. Cheng, et al. 2001. The α(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity. 15:115-126.
30. Streit, M., and M. Detmar. 2003. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene. 22:3172-3179.
31. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
32. van den Broek, M.E., D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W.K. Lutz, C.J. Melief, R.M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781-1790.
33. Shankaran, V., H. Ikeda, A.T. Bruce, J.M. White, P.E. Swanson, L.J. Old, and R.D. Schreiber. 2001. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 410:1107-1111.
34. Street, S.E., Y. Hayakawa, Y. Zhan, A.M. Lew, D. MacGregor, A.M. Jamieson, A. Diefenbach, H. Yagita, D.I. Godfrey, and M.J. Smyth. 2004. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and γδ T cells. J. Exp. Med. 199:879-884.
35. Takeda, K., M.J. Smyth, E. Cretney, Y. Hayakawa, N. Kayagaki, H. Yagita, and K. Okumura. 2002. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J. Exp. Med. 195:161-169.
36. Diefenbach, A., E.R. Jensen, A.M. Jamieson, and D.H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413:165-171.
37. Cerwenka, A., J.L. Baron, and L.L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA. 98:11521-11526.
38. Smyth, M.J., K.Y. Thia, S.E. Street, E. Cretney, J.A. Trapani, M. Taniguchi, T. Kawano, S.B. Pelikan, N.Y. Crowe, and D.I. Godfrey. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191:661-668.
39. Smyth, M.J., M. Taniguchi, and S.E. Street. 2000. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J. Immunol. 165:2665-2670.
40. Takeda, K., M.J. Smyth, E. Cretney, Y. Hayakawa, N. Yamaguchi, H. Yagita, and K. Okumura. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-γ-dependent suppression of subcutaneous tumor growth. Cell. Immunol. 214:194-200.
41. Smyth, M.J., J. Swann, J.M. Kelly, E. Cretney, W.M. Yokoyama, A. Diefenbach, T.J. Sayers, and Y. Hayakawa. 2004. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J. Exp. Med. 200:1325-1335.
42. Salazar-Mather, T.P., J.S. Orange, and C.A. Biron. 1998. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187:1-14.
43. Rossi, F.M.V., S.Y. Corbel, J.S. Merzaban, D.A. Carlow, K. Gossens, J. Duenas, L. So, L. Yi, and H.J. Ziltener. 2005. Recruitment of adult thymic progenitors is regulated by P-selectin and its ligand PSGL-1. Nat. Immunol. 6:626-634.
44. Mackay, C.R., W. Marston, and L. Dudler. 1992. Altered patterns of T cell migration through lymph nodes and skin following antigen challenge. Eur. J. Immunol. 22:2205-2210.
45. Shi, F.D., H.B. Wang, H. Li, S. Hong, M. Taniguchi, H. Link, L. Van Kaer, and H.G. Ljunggren. 2000. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1:245-251.
46. Lee, I.F., H. Qin, J. Trudeau, J. Dutz, and R. Tan. 2004. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J. Immunol. 172:937-942.
47. Glas, R., L. Franksson, C. Une, M.L. Eloranta, C. Ohlen, A. Orn, and K. Karre. 2000. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J. Exp. Med. 191:129-138.
48. Smyth, M.J., J.M. Kelly, A.G. Baxter, H. Korner, and J.D. Sedgwick. 1998. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 188:1611-1619.
49. Julius, M.H., E. Simpson, and L.A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645-649.
50. Masopust, D., V. Vezys, A.L. Marzo, and L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 291:2413-2417.
51. Moore, A., N. Sergeyev, S. Bredow, and R. Weissleder. 1998. A model system to quantitate tumor burden in locoregional lymph nodes during cancer spread. Invasion Metastasis. 18:192-197.
52. Koo, G.C., F.J. Dumont, M. Tutt, J. Hackett Jr., and V. Kumar. 1986. The NK-1.1( ) mouse: a model to study differentiation of murine NK cells. J. Immunol. 137:3742-3747.
53. Seaman, W.E., M. Sleisenger, E. Eriksson, and G.C. Koo. 1987. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138:4539-4544.
54. Takaki, R., Y. Hayakawa, A. Nelson, P.V. Sivakumar, S. Hughes, M.J. Smyth, and L.L. Lanier. 2005. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism. J. Immunol. 175:2167-2173.